Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Pabinger

Showing results (71-80 of 211) with videos related to

Pageof 22
Sort By:
Thrombosis and Haemostasis|February 18, 1985
High levels of plasma protein C in nephrotic syndromeI Pabinger-Fasching, K Lechner, H Niessner, et al.
Blood|March 27, 2001
Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathwayH Deguchi, J A Fernández, I Pabinger, et al.
Thrombosis and Haemostasis|June 28, 1990
Diagnosis of protein C deficiency in patients on oral anticoagulant treatment: comparison of three different functional protein C assaysI Pabinger, P A Kyrle, W Speiser, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1993
Twelve novel and two recurrent mutations in 14 Austrian families with hereditary protein C deficiencyS R Poort, I Pabinger-Fasching, C Mannhalter, et al.
Thrombosis and Haemostasis|August 3, 1992
Multicenter evaluation of three commercial methods for measuring protein S antigenA Tripodi, R M Bertina, J Conard, et al.
Thrombosis Research|May 11, 2016
PO-01 - Congestive heart failure is an independent risk factor for venous thromboembolism and mortality in cancer patientsO Königsbrügge, J Riedl, E Grilz, et al.
Hamostaseologie|October 11, 2011
[Venous thrombembolism in tumour patients]I Pabinger, B Alt-Epping, F Demarmels Biasutti, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 11, 2006
Laboratory issues in bleeding disordersD Lillicrap, S C Nair, A Srivastava, et al.
American Journal of Hematology|March 1, 1987
Incidence of inhibitors in patients with severe and moderate hemophilia A treated with factor VIII concentratesI Schwarzinger, I Pabinger, C Korninger, et al.
Lupus|September 1, 2006
Specificities of platelet autoantibodies and platelet activation in lupus anticoagulant patients: a relation to their history of thromboembolic diseaseK Schallmoser, C Rosin, R Vormittag, et al.
Pageof 22

Showing results (71-80 of 211) with videos related to

Sort By:
Pageof 22
Thrombosis and Haemostasis|February 18, 1985
High levels of plasma protein C in nephrotic syndromeI Pabinger-Fasching, K Lechner, H Niessner, et al.
Blood|March 27, 2001
Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathwayH Deguchi, J A Fernández, I Pabinger, et al.
Thrombosis and Haemostasis|June 28, 1990
Diagnosis of protein C deficiency in patients on oral anticoagulant treatment: comparison of three different functional protein C assaysI Pabinger, P A Kyrle, W Speiser, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1993
Twelve novel and two recurrent mutations in 14 Austrian families with hereditary protein C deficiencyS R Poort, I Pabinger-Fasching, C Mannhalter, et al.
Thrombosis and Haemostasis|August 3, 1992
Multicenter evaluation of three commercial methods for measuring protein S antigenA Tripodi, R M Bertina, J Conard, et al.
Thrombosis Research|May 11, 2016
PO-01 - Congestive heart failure is an independent risk factor for venous thromboembolism and mortality in cancer patientsO Königsbrügge, J Riedl, E Grilz, et al.
Hamostaseologie|October 11, 2011
[Venous thrombembolism in tumour patients]I Pabinger, B Alt-Epping, F Demarmels Biasutti, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 11, 2006
Laboratory issues in bleeding disordersD Lillicrap, S C Nair, A Srivastava, et al.
American Journal of Hematology|March 1, 1987
Incidence of inhibitors in patients with severe and moderate hemophilia A treated with factor VIII concentratesI Schwarzinger, I Pabinger, C Korninger, et al.
Lupus|September 1, 2006
Specificities of platelet autoantibodies and platelet activation in lupus anticoagulant patients: a relation to their history of thromboembolic diseaseK Schallmoser, C Rosin, R Vormittag, et al.
Pageof 22